Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Check-Cap

Market Cap 9.99M 8.62M 7.95M 7.44M 13.94M 949M 14.16M 93.84M 36.59M 462M 37.47M 36.68M 1.6B P/E Ratio 2024
-0.23x
P/E Ratio 2025 2.44x
Enterprise Value 9.78M 8.45M 7.79M 7.29M 13.66M 930M 13.87M 91.93M 35.84M 453M 36.71M 35.93M 1.57B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+1.46%
1 week+0.72%
Current month-13.12%
1 month-17.75%
3 months-15.76%
6 months-19.19%
Current year-14.20%
1 week 1.29
Extreme 1.29
1.48
1 month 1.29
Extreme 1.29
2.1
Current year 1.29
Extreme 1.29
3.92
1 year 0.59
Extreme 0.593
3.92
3 years 0.56
Extreme 0.56
4.62
5 years 0.56
Extreme 0.56
34.4
10 years 0.56
Extreme 0.56
820.8
Manager TitleAgeSince
Chief Executive Officer 45 2024-07-16
Director of Finance/CFO 51 2025-04-05
Human Resources Officer - 2008-12-31
Director TitleAgeSince
Director/Board Member 51 2025-04-05
Director/Board Member 53 2024-01-24
Chairman 45 2024-01-24

Financials

2024 2025
Net sales - -
Net income -25.15M -21.72M -20.02M -18.74M -35.11M -2.39B -35.66M -236M -92.15M -1.16B -94.38M -92.37M -4.03B 4.14M 3.58M 3.3M 3.08M 5.78M 394M 5.87M 38.91M 15.17M 192M 15.54M 15.21M 663M
Net Debt -129K -111K -103K -96.1K -180K -12.26M -183K -1.21M -473K -5.97M -484K -474K -20.66M -203K -175K -162K -151K -283K -19.3M -288K -1.91M -744K -9.39M -762K -746K -32.52M
Logo Check-Cap
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Employees
85
Sector
-
Date Price Change Volume
26-06-12 1.390 $ +1.46% 31,128
26-06-11 1.370 $ +3.01% 54,275
26-06-10 1.330 $ -5.00% 57,839
26-06-09 1.400 $ -5.41% 86,453
26-06-08 1.480 $ +7.25% 44,504
  1. Stock Market
  2. Stocks
  3. MBAI Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!